REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,708 | +25.4% | 300 | -50.0% | 0.00% | +100.0% |
| Q2 2023 | $41,247 | +287.0% | 600 | +100.0% | 0.00% | – |
| Q1 2023 | $10,659 | +88725.0% | 300 | -6.5% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 321 | -24.1% | 0.00% | – |
| Q3 2022 | $19,000 | 0.0% | 423 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $19,000 | -36.7% | 423 | -41.5% | 0.00% | – |
| Q1 2022 | $30,000 | +275.0% | 723 | +141.0% | 0.00% | – |
| Q4 2021 | $8,000 | +60.0% | 300 | +500.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 50 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | +40.0% | 50 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +20.0% | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |